Macrophage targeted theranostic strategy for accurate detection and rapid stabilization of the inflamed high-risk plaque
- Authors
- Song, Joon Woo; Nam, Hyeong Soo; Ahn, Jae Won; Park, Hyun-Sang; Kang, Dong Oh; Kim, Hyun Jung; Kim, Yeon Hoon; Han, Jeongmoo; Choi, Jah Yeon; Lee, Seung-Yul; Kim, Sunwon; Oh, Wang-Yuhl; Yoo, Hongki; Park, Kyeongsoon; Kim, Jin Won
- Issue Date
- 2021
- Publisher
- IVYSPRING INT PUBL
- Keywords
- atherosclerosis; targeted theranostics; drug delivery; PPAR gamma; OCT-NIRF
- Citation
- THERANOSTICS, v.11, no.18, pp.8874 - 8893
- Indexed
- SCIE
SCOPUS
- Journal Title
- THERANOSTICS
- Volume
- 11
- Number
- 18
- Start Page
- 8874
- End Page
- 8893
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/138705
- DOI
- 10.7150/thno.59759
- ISSN
- 1838-7640
- Abstract
- Rationale: Inflammation plays a pivotal role in the pathogenesis of the acute coronary syndrome. Detecting plaques with high inflammatory activity and specifically treating those lesions can be crucial to prevent life-threatening cardiovascular events. Methods: Here, we developed a macrophage mannose receptor (MMR)-targeted theranostic nanodrug (mannose-polyethylene glycol-glycol chitosan-deoxycholic acid-cyanine 7-lobeglitazone; MMR-Lobe-Cy) designed to identify inflammatory activity as well as to deliver peroxisome proliferator-activated gamma (PPAR gamma) agonist, lobeglitazone, specifically to high-risk plaques based on the high mannose receptor specificity. The MMR-Lobe-Cy was intravenously injected into balloon-injured atheromatous rabbits and serial in vivo optical coherence tomography (OCT)-near-infrared fluorescence (NIRF) structural molecular imaging was performed. Results: One week after MMR-Lobe-Cy administration, the inflammatory NIRF signals in the plaques notably decreased compared to the baseline whereas the signals in saline controls even increased over time. In accordance with in vivo imaging findings, ex vivo NIRF signals on fluorescence reflectance imaging (FRI) and plaque inflammation by immunostainings significantly decreased compared to oral lobeglitazone group or saline controls. The anti-inflammatory effect of MMR-Lobe-Cy was mediated by inhibition of TLR4/NF-Kappa B pathway. Furthermore, acute resolution of inflammation altered the inflamed plaque into a stable phenotype with less macrophages and collagen-rich matrix. Conclusion: Macrophage targeted PPAR gamma activator labeled with NIRF rapidly stabilized the inflamed plaques in coronary sized artery, which could be quantitatively assessed using intravascular OCT-NIRF imaging. This novel theranostic approach provides a promising theranostic strategy for high-risk coronary plaques.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
- Graduate School > Department of Biomedical Sciences > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.